Karen Marie Johnson bought TOI once, on Mar 26, 2025

Karen Marie Johnson is a corporate insider and director at The Oncology Institute, Inc. (NASDAQ: TOI), where she serves on the board of directors and is reported in SEC filings as holding the role of Director.( As a TOI director, she participates in the company’s governance and oversight and has received board fees in connection with her service, as disclosed in the company’s SEC-filed annual report.(

Johnson has been an active shareholder in The Oncology Institute; in March 2025 she acquired 36,224 shares of common stock via a private placement at approximately $37,734 in total consideration, along with 18,112 common warrants exercisable through March 2030, resulting in beneficial ownership exceeding 200,000 shares of TOI common stock following these transactions.( These activities, recorded on Form 4 and summarized in insider ownership reports, underscore her role as a significant individual insider rather than a corporate entity.(

Written by Perplexity from public sources.